Larry C Heaton II bought $28k of ZOMDF
CEO at Zomedica Corp.. 250,000 shares at an average of $0.11, traded May 8, 2026, filed May 8, 2026.
Score components
- +25RoleCEO
- +5Trade size$28k at market
- +6Relative to holdingsHoldings up 25%
- +4Price context25% below the 52-week high
- +15Cluster3 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (1 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -13.9%, 3m -27.0%, 6m -.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001654954-26-004631, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 8, 2026 | POpen-market purchase Common Stock, without par value | +250,000 | $0.11 | $28k | 1,250,000 | May 8, 2026 |
Related signals
Other insiders at Zomedica Corp. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 56Moderate | Zomedica Corp. | Russell Kevin Klass Sr. Vice President, Sales | $11k 104,000 shares | - | |
| 36Weak | Zomedica Corp. | Russell Kevin Klass Vice President of Sales | $23k 216,899 shares | +4% | |
| 43Moderate | Zomedica Corp. | Johnny D Powers director | $21k 200,000 shares | +5% | |
| 51Moderate | Zomedica Corp. | Johnny D Powers director | $32k 300,000 shares | +8% | |
| 44Moderate | Zomedica Corp. | Johnny D Powers director | $56k 500,000 shares | +15% | |
| 28Weak | ZOMDFbuy Zomedica Corp. | Russell Kevin Klass Sr Vice President, Sales | $15k 150,000 shares | +3% | |
| 28Weak | ZOMDFbuy Zomedica Corp. | Russell Kevin Klass Sr Vice President, Sales | $12k 120,000 shares | +2% | |
| 23Weak | ZOMDFbuy Zomedica Corp. | Russell Kevin Klass Sr Vice President, Sales | $475 5,000 shares | +0% | |
| 28Weak | ZOMDFbuy Zomedica Corp. | Russell Kevin Klass Sr Vice President, Sales | $20k 253,007 shares | +5% | |
| 40Moderate | ZOMDFbuy Zomedica Corp. | Russell Kevin Klass Sr Vice President, Sales | $42k 1,056,064 shares | +25% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.